Fusen Pharmaceutical Company Limited

1652.HK | Healthcare | HKSE
$0.82
+0.02 (+2.50%)

Key Metrics

Market Cap
$606.23M
P/E Ratio
-3.15
EPS
$-0.26
Beta
N/A
Dividend Yield
N/A
ROE
-48.86%
Current Ratio
0.57

Company Information

Industry
Drug Manufacturers Specialty Generic

About Fusen Pharmaceutical Company Limited

Fusen Pharmaceutical Company Limited an investment holding company manufactures and sells pharmaceutical products in the Peoples Republic of China The companys product portfolio includes Shuanghuanglianbased cold medicines comprising Shuanghuanglian oral solutions and Shuanghuanglian injections and flunarizine hydrochloride capsules and compound ferrous sulfate granules as well as Yuanhu Zhitong oral solutions Ganweikang tablets and Yixinkang tablets In addition it researches develops produces and sells various proprietary Chinese medicines and western medicine products for the treatment of cold and fever cardiovascular diseases and anemia Further the company offers business management and consulting services Fusen Pharmaceutical Company Limited was founded in 2003 and is headquartered in Nanyang China

Financial Ratios (TTM)

Gross Margin
41.39%
Operating Margin
-21.23%
Net Margin
-72.61%
ROA
-14.20%
Price to Book
1.56
Price to Sales
2.25